乙呱仑 | 99287-30-6

• 分子结构分类: 有机化合物 - 碳氢化合物 - 不饱和烃
• 中文名称: 乙呱仑
• 英文名称: Egualen
• 英文别名: 3-ethyl-7-propan-2-ylazulene-1-sulfonic acid
• CAS: 99287-30-6
• 化学式: C₁₅H₁₈O₃S
• 分子量: 278.4
• InChiKey: NARQSHREEUXZBT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  62.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
  申请人：Rogers D. Robin

  公开号：US20070093462A1

  公开（公告）日：2007-04-26

  Disclosed are ionic liquids and methods of preparing ionic liquid compositions of active pharmaceutical, biological, nutritional, and energetic ingredients. Also disclosed are methods of using the compositions described herein to overcome polymorphism, overcome solubility and delivery problems, to control release rates, add functionality, enhance efficacy (synergy), and improve ease of use and manufacture.

  揭示了离子液体及制备活性药物、生物、营养和能量成分的离子液体组合物的方法。还揭示了利用本文描述的组合物的方法，以克服多型性、克服溶解度和输送问题、控制释放速率、增加功能性、增强功效（协同作用）以及改善易用性和制造工艺。
• [EN] DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF<br/>[FR] LIQUIDES IONIQUES À DOUBLE FONCTION ET SELS DE CEUX-CI
  申请人：UNIV ALABAMA

  公开号：WO2010078300A1

  公开（公告）日：2010-07-08

  Disclosed herein are ionic liquid compositions comprising active pharmaceutical, biological, and nutritional compounds, and methods of use. Further disclosed are compositions of matter including liquid ion pairs alone or in solution and their use; compositions of ionic liquids that are 'solvated,' for example, 'hydrated' and their uses.

  本文揭示了包括活性药物、生物学和营养化合物的离子液体组合物，以及其使用方法。进一步揭示了包括液态离子对的物质组合物，单独或溶解后使用；以及离子液体的“溶剂化”组合物，例如“水合”的组合物及其用途。
• Bicyclic compound
  申请人：Miyoshi Shiro

  公开号：US20060069098A1

  公开（公告）日：2006-03-30

  A novel compound represented by the following formula (1) or a salt thereof: wherein symbol “A” represents a saturated heterocyclic group, a 5-membered heteroaromatic group having two heteroatoms in the ring, a group represented by the formula A1 (R 2 , R 3 , and R 4 represent hydrogen atom, hydroxyl group, etc.), etc., B represents a group represented by the formula B1 (R 11 represents hydrogen atom, hydroxyl group, etc.), etc., R 1 represents an alkyl group, and symbol “n” represents an integer of 2 to 6, which has a parathyroid hormone depressing action and showing low toxicity, and a medicament containing the compound or salt thereof as an active ingredient.

  以下公式（1）所代表的一种新化合物或其盐：其中符号“A”代表饱和杂环基，一个含有两个杂原子的5元杂芳基，一个由公式A1（R2、R3和R4代表氢原子、羟基等）所代表的基团，等等，B代表由公式B1（R11代表氢原子、羟基等）所代表的基团，等等，R1代表烷基，符号“n”代表一个整数，范围为2至6，具有降钙素抑制作用和低毒性，并且含有该化合物或其盐作为活性成分的药物。
• Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
  申请人：——

  公开号：US20020016342A1

  公开（公告）日：2002-02-07

  The present invention provides a method for the treatment or prophylaxis of COX-2-mediated conditions in patients who are at risk of developing thromboembolic events which comprises administering to said patient a therapeutically or prophylactically effective amount of a COX-2 selective inhibitor and a cardiovascular protective amount of a thromboxane inhibitor, as well as compositions therefor.

  本发明提供了一种治疗或预防COX-2介导的病症的方法，适用于有发生血栓栓塞事件风险的患者，包括向该患者施用治疗或预防有效量的COX-2选择性抑制剂和心血管保护量的血栓素抑制剂，以及相应的组合物。
• CRYSTALLINE FORM OF PEMIROLAST
  申请人：RSPR Pharma AB

  公开号：US20160250217A1

  公开（公告）日：2016-09-01

  There is provided a hemihydrate form of the sodium salt of pemirolast.

  提供了一种半水合物形式的佩米罗拉司特钠盐。